{"transactions":[{"id":706425,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:13:30.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":186944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":186944,"derivative":{"exercise_price":3.2,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":186944},"source":{"system":"sec-edgar","filing":"0001796436-26-000002","document":"wk-form4_1784319208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000179643626000002/wk-form4_1784319208.xml","form_type":"4"}},{"id":921043,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T21:42:10.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":147200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":147200,"derivative":{"exercise_price":8.1,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":147200},"source":{"system":"sec-edgar","filing":"0001601485-26-000010","document":"wk-form4_1770154928.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000010/wk-form4_1770154928.xml","form_type":"4"}},{"id":921042,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2026-02-03T21:42:10.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":73600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."}],"balance_after":120570,"source":{"system":"sec-edgar","filing":"0001601485-26-000010","document":"wk-form4_1770154928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000010/wk-form4_1770154928.xml","form_type":"4"}},{"id":1283716,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:08:31.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":121600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the options on the first anniversary of the grant date (February 3, 2026), with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":121600,"derivative":{"exercise_price":8.92,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":121600},"source":{"system":"sec-edgar","filing":"0001601485-25-000012","document":"wk-form4_1738703302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000012/wk-form4_1738703302.xml","form_type":"4"}},{"id":1393703,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-02T20:14:33.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":91600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the stock options vest on September 30, 2025, the one-year anniversary of the grant date, with the remaining fifty percent (50%) of the stock options to vest on September 30, 2026, the two-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":91600,"derivative":{"exercise_price":5.03,"expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":91600},"source":{"system":"sec-edgar","filing":"0001601485-24-000053","document":"wk-form4_1727900067.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000053/wk-form4_1727900067.xml","form_type":"4"}},{"id":1658168,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29684,"kind":"person","name":"Connelly Robert","position":1,"cik":"0001796436","reported_name":"Connelly Robert","relationship":{"director":true,"officer":true,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-05T11:01:44.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":225137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":225137,"derivative":{"exercise_price":4.5,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":225137},"source":{"system":"sec-edgar","filing":"0001140361-24-005498","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124005498/form4.xml","form_type":"4"}}]}